The radiation biology of radioimmunotherapy
- 1 September 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 24 (9) , 951-957
- https://doi.org/10.1097/00006231-200309000-00002
Abstract
The treatment of cancer is a wide and varied field, encompassing many methods and modalities. Radioimmunotherapy is a technique which utilizes the ablative properties of radiation by delivering radioactive particles directly to the tumour cells. This paper presents a summary of the research evidence that relates to the optimization of the effect of radioimmunotherapy. It includes discussion on the appropriate choice of radionuclide and monoclonal antibody; methods of increasing the radiation dose absorbed by the tumour; techniques available to increase the effect that the absorbed dose has on the tumour; and methods of protecting critical healthy tissue, particularly the bone marrow, from the effects of the radiation administered.Keywords
This publication has 13 references indexed in Scilit:
- Hematologic MalignanciesThe Oncologist, 2001
- Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphomaCancer Chemotherapy and Pharmacology, 2001
- The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapyCritical Reviews in Oncology/Hematology, 2001
- Antibody therapy of lymphomaExpert Opinion on Pharmacotherapy, 2001
- Radioimmunotherapy with Alpha-Particle Emitters: Microdosimetry of Cells with a Heterogeneous Antigen Expression and with Various Diameters of Cells and NucleiRadiation Research, 2001
- Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear–quadratic formulationInternational Journal of Radiation Biology, 2001
- Radioimmunotherapy in the π-BCL1B cell Lymphoma Model: Efficacy Depends on More Than Targeted Irradiation AloneCancer Biotherapy & Radiopharmaceuticals, 2000
- Analytic microdosimetry for radioimmunotherapeutic alpha emittersMedical Physics, 1992
- 212Bismuth Linked to an Antipancreatic Carcinoma Antibody: Model for Alpha-Particle-Emitter RadioimmunotherapyJNCI Journal of the National Cancer Institute, 1988
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975